BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34563184)

  • 1. A novel heterozygous mutation of CHD7 gene in a Chinese patient with Kallmann syndrome: a case report.
    Xu W; Zhou W; Lin H; Ye D; Chen G; Dong F; Shen J
    BMC Endocr Disord; 2021 Sep; 21(1):193. PubMed ID: 34563184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
    Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG; Layman LC
    Mol Cell Endocrinol; 2011 Oct; 346(1-2):74-83. PubMed ID: 21856375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic Spectrum of Idiopathic Hypogonadotropic Hypogonadism Patients With CHD7 Variants From a Large Chinese Cohort.
    Li JD; Wu J; Zhao Y; Wang X; Jiang F; Hou Q; Chen DN; Zheng R; Yu R; Zhou W; Men M
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31689711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eight rare urinary disorders in a patient with Kallmann syndrome: A case report.
    Tian H; Yan Z; Lv Y; Sun L; Gang X; Wang G
    Medicine (Baltimore); 2020 Oct; 99(43):e22936. PubMed ID: 33120852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.
    Jongmans MC; van Ravenswaaij-Arts CM; Pitteloud N; Ogata T; Sato N; Claahsen-van der Grinten HL; van der Donk K; Seminara S; Bergman JE; Brunner HG; Crowley WF; Hoefsloot LH
    Clin Genet; 2009 Jan; 75(1):65-71. PubMed ID: 19021638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.
    Marcos S; Sarfati J; Leroy C; Fouveaut C; Parent P; Metz C; Wolczynski S; Gérard M; Bieth E; Kurtz F; Verier-Mine O; Perrin L; Archambeaud F; Cabrol S; Rodien P; Hove H; Prescott T; Lacombe D; Christin-Maitre S; Touraine P; Hieronimus S; Dewailly D; Young J; Pugeat M; Hardelin JP; Dodé C
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2138-43. PubMed ID: 25077900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
    Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
    PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome.
    Bergman JE; de Ronde W; Jongmans MC; Wolffenbuttel BH; Drop SL; Hermus A; Bocca G; Hoefsloot LH; van Ravenswaaij-Arts CM
    J Clin Endocrinol Metab; 2012 May; 97(5):E858-62. PubMed ID: 22399515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallmann syndrome phenotype in a female patient with CHARGE syndrome and CHD7 mutation.
    Ogata T; Fujiwara I; Ogawa E; Sato N; Udaka T; Kosaki K
    Endocr J; 2006 Dec; 53(6):741-3. PubMed ID: 16960397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionally compromised CHD7 alleles in patients with isolated GnRH deficiency.
    Balasubramanian R; Choi JH; Francescatto L; Willer J; Horton ER; Asimacopoulos EP; Stankovic KM; Plummer L; Buck CL; Quinton R; Nebesio TD; Mericq V; Merino PM; Meyer BF; Monies D; Gusella JF; Al Tassan N; Katsanis N; Crowley WF
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17953-8. PubMed ID: 25472840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical data and genetic mutation in Kallmann syndrome with CHARGE syndrome: Case report and pedigree analysis.
    Wen J; Pan L; Xu X; Wang J; Hu C
    Medicine (Baltimore); 2018 Jul; 97(27):e11284. PubMed ID: 29979396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Quaynor SD; Kim HG; Cappello EM; Williams T; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Fertil Steril; 2011 Dec; 96(6):1424-1430.e6. PubMed ID: 22035731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism.
    Aoyama K; Mizuno H; Tanaka T; Togawa T; Negishi Y; Ohashi K; Hori I; Izawa M; Hamajima T; Saitoh S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1111-1118. PubMed ID: 28915117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diagnosis of idiopathic hypogonadotrophic hypogonadism: a new point mutation in the KAL2 gene.
    Entrala-Bernal C; Montes-Castillo C; Alvarez-Cubero MJ; Gutiérrez-Alcántara C; Fernandez-Rosado F; Martinez-Espίn E; Sánchez-Malo C; Santiago-Fernández P
    Hormones (Athens); 2014; 13(2):280-5. PubMed ID: 24776628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Xu N; Kim HG; Bhagavath B; Cho SG; Lee JH; Ha K; Meliciani I; Wenzel W; Podolsky RH; Chorich LP; Stackhouse KA; Grove AM; Odom LN; Ozata M; Bick DP; Sherins RJ; Kim SH; Cameron RS; Layman LC
    Fertil Steril; 2011 Apr; 95(5):1613-20.e1-7. PubMed ID: 21300340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants.
    Xu C; Cassatella D; van der Sloot AM; Quinton R; Hauschild M; De Geyter C; Flück C; Feller K; Bartholdi D; Nemeth A; Halperin I; Pekic Djurdjevic S; Maeder P; Papadakis G; Dwyer AA; Marino L; Favre L; Pignatelli D; Niederländer NJ; Acierno J; Pitteloud N
    Genet Med; 2018 Aug; 20(8):872-881. PubMed ID: 29144511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.